Last $170.06 USD
Change Today -0.51 / -0.30%
Volume 1.3M
AGN On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter J. McDonnell M.D.

Independent Director, Member of Corporate Governance & Compliance Committee and Member of Science & Technology Committee, Allergan Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
55$427,232

Background*

Dr. Peter J. McDonnell, M.D., has been the Chief Medical Editor of Ophthalmology Times since 2004. Dr. McDonnell has been Director and Wilmer Holland Wilmer Professor of Ophthalmology at the Wilmer Eye Institute, the Johns Hopkins University School of Medicine, Baltimore, Maryland since 2003. He served as the Chief resident at Wilmer Eye Institute. Dr. McDonnell also served as an Assistant Chief of Service at the Wilmer Institute from 1987 to 1988. He has been an Independent ...

Read Full Background

Corporate Headquarters*

2525 Dupont Drive
Irvine, California 92612

United States

Phone: 714-246-4500
Fax: 714-246-6987

Board Members Memberships*

2013-Present
Independent Director, Member of Corporate Governance & Compliance Committee and Member of Science & Technology Committee

Education*

MD
Johns Hopkins School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$75,000
Total Calculated Compensation$427,232
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGN:US $170.06 USD -0.51

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Stefan F. Heidenreich Chairman of Executive Board and Chief Executive Officer
Beiersdorf AG
€1.8M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.